Learn more about the effects of beta-hydroxybutyrate (BHB) on motor dysfunction and brain damage in a mouse model of traumatic brain injury (TBI). The research investigates both prophylactic (pre-injury) and therapeutic (post-injury) BHB treatments, assessing their impact on motor function using a beam walk test and measuring levels of ubiquitin carboxy-terminal hydrolase L1 (UCH-L1), a biomarker of brain damage. The findings suggest that BHB treatments improve motor outcomes and reduce brain damage markers after TBI.
Explore this poster to learn about:
- The potential of metabolic therapies to enhance recovery from neural injuries by targeting both functional and molecular aspects of brain health.
- How strategic treatment timing can optimize therapeutic outcomes in the context of injury prevention and recovery.
- Innovative approaches using alternative energy sources for neuroprotection and mitigating damage after traumatic brain injury.
Click here to download this scientific poster!
Discover how our specialized models and services can accelerate your TBI drug discovery. Learn more today!
